October 26, 2017
Onxeo Provides Strategy Update and Reports 2017 Third Quarter Financial Information
Media
October 26, 2017
GenSight Biologics Reports its Cash Position as of September 30, 2017
October 26, 2017
Cash position and activity update for Q3 2017
October 25, 2017
Nexstim raises EUR 1.75 million via a directed issue of new shares to London-based investor City Financial – Funds to be used to support beginning the commercialisation of its NBT® system
October 25, 2017
GenSight Biologics Appoints Barrett Katz as Chief Medical Officer
October 24, 2017
Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November
October 23, 2017
Nordic Nanovector: Presentations at European Association of Nuclear Medicine annual meeting (EANM)
October 23, 2017
Wilson Therapeutics reaches agreement with the FDA and EMA to initiate pivotal Phase 3 FOCuS study with WTX101 in Wilson Disease
October 20, 2017
Promising preliminary long-term data for WTX101 in Wilson Disease highlighted at The Liver Meeting®
October 19, 2017
BONESUPPORT HOLDING AB (publ) – Q3 2017 Interim Report – invitation to conference call and webcast